DISCLOSEDQuarterly
Two Sigma Investments
Axsome Therapeutics Inc. · NASDAQ
679,978 sh · $166.4M
Filed 30 Jun 2026SEC 13Fview source
BlackRock
13F filer
$265.6M
3,299,991 sh
Two Sigma Investments
13F filer
$166.4M
679,978 sh
Renaissance Technologies
13F filer
$27.8M
164,300 sh
Bridgewater Associates
13F filer
$9.6M
56,951 sh
Polen Capital Management
13F filer
$1.1M
4,468 sh
Two Sigma Investments
Axsome Therapeutics Inc. · NASDAQ
679,978 sh · $166.4M
Polen Capital Management
Axsome Therapeutics Inc. · NASDAQ
4,468 sh · $1.1M
Bridgewater Associates
Axsome Therapeutics Inc. · NASDAQ
56,951 sh · $9.6M
Two Sigma Investments
Axsome Therapeutics Inc. · NASDAQ
326,478 sh · $55.2M
Polen Capital Management
Axsome Therapeutics Inc. · NASDAQ
2,116 sh · $357.6K
Renaissance Technologies
Axsome Therapeutics Inc. · NASDAQ
164,300 sh · $27.8M
BlackRock
Axsome Therapeutics Inc. · NASDAQ
3,299,991 sh · $265.6M